Market Trends of Lab Automation For In-Vitro Diagnostics Industry
Adoption of Robotics Arms Aids the Market Growth
- In-vitro diagnostics (IVD) has become indispensable in the healthcare system by providing critical information to diagnose diseases and guide therapeutic decisions. The scope of robotic surgery, the transition from open to laparoscopic surgery, and the demand for surgeons with expertise in complex robotic medical procedures will all expand.
- Clinical diagnostics and in vitro diagnostic (IVD) markets benefit from current advancements in automation and robotics, such as enhanced liquid handling robot solutions rather than individual pipetting chores or other types of manual handling. Robotic ultrasound has been tested in various settings, including operating rooms, remote clinics, and space.
- Robotic arms are increasingly used in research laboratories for applications requiring flexibility, efficient space utilization, and seamless integration of lab peripherals. Adoption has grown over time due to the ease with which the arms can be programmed. As a result, the market will be driven by the increased adoption of robotic arms for lab automation.
- The most common application of robotics in laboratories is machine tending or pick and place to reduce labor requirements and increase productivity. However, thanks to advancements in modular equipment, even small laboratories can reap the benefits of automation. With the assistance of various vendors, laboratories of all sizes are quickly realizing the many advantages of robotic laboratory automation.
- Because of technological advancements and increased demand for results, laboratories are increasingly utilizing automated systems. Because of its precision, improved data management capabilities, reduced repetitiveness, and eventually less human intervention, lab automation is becoming more popular, resulting in higher throughput and accuracy. For example, a robot arm for sorting blood samples reduces hospital diagnostic center personnel's workload while ensuring safety.
- Moreover, IoT-enabled systems provide server control and monitoring of various sensors and can be easily configured to handle additional hardware interface modules. Sensors installed in robots and loaded onto devices may aid data collection and communication with cloud servers and other devices. Furthermore, laboratories can maintain data with high levels of security while providing accurate and unaltered data via IoT.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Hold Significant Market Share
- North America dominates the lab automation for the in-vitro diagnostics market due to the presence of large pharmaceutical companies and the rapid increase in investment in the drug discovery and genomics sectors. The United States, on the other hand, is expected to have a significant growth rate during the forecast period due to the increased development of novel technologies, rapid population growth, and continuous technological advancements.
- North America has been a leader in clinical research for many years. Pfizer, Novartis, GlaxoSmithKline, J&J, and Novartis are among the major pharmaceutical companies headquartered in this region. In addition, the area has the greatest concentration of contract research organizations (CROs). Some significant CROs are Laboratory Corp. of America Holdings, IQVIA, Syneos Health, and Parexel International Corp.
- Because of the availability of government funds, stringent FDA regulations, the growing use of molecular diagnostics in genetic disorders and cancer screening, and most of the major players in this region, the region is expected to account for a major market share.
- Additionally, the growing number of surgeries and the prevalence of various chronic diseases drive demand for automation in the clinical diagnostics industry. The American Orthopedic Surgeons (AAOS) predicts that approximately 3.0 million total knee arthroplasty surgeries will be performed in the United States by 2030. The diagnosis of these and other chronic conditions necessitates sample collection, which increases demand for the market under consideration.
- Moreover, increased access to superior technologies, increased demand for laboratory automation, and the expansion of molecular diagnostics for genetic disorders and cancer screening in the United States may all boost market demand in North America. SmartLabs, a Boston-based Laboratory-as-a-Service (LaaS) leader, announced plans to open its first facility in the city in August 2022, in addition to SmartLabs' advanced resourcing in Boston and the Bay Area, which is expected to become the city's most prominent life sciences research and production space upon completion in 2025.
Get Analysis on Important Geographic Markets
Download PDF
